Patents by Inventor Seyed Moien MOGHIMI

Seyed Moien MOGHIMI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDIC BLOCKS FOR NUCLEIC ACID DELIVERY
    Publication number: 20240131174
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Application
    Filed: August 18, 2023
    Publication date: April 25, 2024
    Inventors: Seyed Moien MOGHIMI, Linping WU, Davoud AHMADVAND, Ladan PARHAMIFAR
  • Peptidic blocks for nucleic acid delivery
    Patent number: 11730820
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: August 22, 2023
    Assignee: S. M. Discovery Group Inc.
    Inventors: Seyed Moien Moghimi, Linping Wu, Davoud Ahmadvand, Ladan Parhamifar
  • PEPTIDIC BLOCKS FOR NUCLEIC ACID DELIVERY
    Publication number: 20210290773
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Application
    Filed: April 2, 2021
    Publication date: September 23, 2021
    Applicant: S. M. Discovery Group Inc.
    Inventors: Seyed Moien MOGHIMI, Linping Wu, Davoud Ahmadvand, Ladan Parhamifar
  • Peptidic self-assembly for nucleic acid delivery
    Patent number: 11000599
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: May 11, 2021
    Assignee: S. M. Discovery Group Inc.
    Inventors: Seyed Moien Moghimi, Linping Wu, Davoud Ahmadvand, Ladan Parhamifar
  • PEPTIDIC SELF-ASSEMBLY FOR NUCLEIC ACID DELIVERY
    Publication number: 20200069813
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Application
    Filed: May 29, 2018
    Publication date: March 5, 2020
    Inventors: Seyed Moien MOGHIMI, Linping WU, Davoud AHMADVAND, Ladan PARHAMIFAR
  • Peptidic nanodelivery composition targeting two receptors
    Patent number: 9981047
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Grant
    Filed: August 19, 2014
    Date of Patent: May 29, 2018
    Inventors: Seyed Moien Moghimi, Linping Wu, Davoud Ahmadvand, Ladan Parhamifarr, Thomas Lars Andresen
  • PEPTIDIC NANODELIVERY COMPOSITION TARGETING TWO RECEPTORS
    Publication number: 20160271269
    Abstract: A polypeptide conjugate for use in a method for binding and/or internalization of the polypeptide conjugate to a mammalian cell having a transferrin receptor (TFRC) and/or receptor for advanced glycation end products (RAGE). The polypeptide conjugate may be used in a method for targeting of a drug delivery system or diagnostic delivery system.
    Type: Application
    Filed: August 19, 2014
    Publication date: September 22, 2016
    Inventors: Seyed Moien MOGHIMI, Linping WU, Davoud AHMADVAND, Ladan HAMIFARR, Thomas Lars ANDRESEN